|
[1]MEHRABI A, KASHFI A, FONOUNI H, et al.Primary malignant hepatic epithelioid hemangioendothelioma:A comprehensive review of the literature with emphasis on the surgical therapy[J].Cancer, 2006, 107 (9) :2108-2121.
|
|
[2]YE F, JIANG LM, SONG Y, et al.Imaging features of hepatic epithelioid hemangioendothelioma[J].Chin J Dig Surg, 2017, 16 (2) :201-206. (in Chinese) 叶枫, 蒋力明, 宋颖, 等.肝脏上皮样血管内皮瘤的影像学特征[J].中华消化外科杂志, 2017, 16 (2) :201-206.
|
|
[3]ZHANG SH, CONG WM, WU MC, et al.Epithelioid hemangioendothelioma of the liver:A clinicopathological study on 8cases and review of literature[J].Chin J Hepatobiliary Surg, 2003, 9 (6) :327-330. (in Chinese) 张树辉, 丛文铭, 吴孟超.肝上皮样血管内皮瘤的临床病理特点 (附8例报告及文献复习) [J].中华肝胆外科杂志, 2003, 9 (6) :327-330.
|
|
[4]KAWAOKA T, AIKATA H, HYOGO H, et al, Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma[J].J Dig Dis, 2015, 16 (9) :505-512.
|
|
[5]EMAMAULLEE JA, EDGAR R, TOSO C, et al.Vascular endothelial growth factor expression in hepatic epithelioid hemangioendothelioma:Implications for treatment and surgical management[J].Liver Transpl, 2010, 16 (2) :191-197.
|
|
[6]SANGRO B, INARRAIRAEGUI M, FERNANDEZ-ROS N.Malignant epithelioid hemangioendothelioma of the liver successfully treated with sorafenib[J].Rare Tumors, 2012, 4 (2) :e34.
|
|
[7]SEMENISTY V, NARODITSKY I, KEIDAR Z, et al.Pazopanib for metastatic pulmonary epithelioid hemangioendothelioma-a suitable treatment option:Case report and review of anti-angiogenic treatment options[J].BMC Cancer, 2015, 15 (1) :1-5.
|
|
[8]KOLLAR A, JONES RL, STACCHIOTTI S, et al.Pazopanib in advanced vascular sarcomas:An EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis[J].Acta Oncol, 2017, 56 (1) :88-92.
|
|
[9]NIZAMI I, MOHAMMED S, ABOUZIED MEL D.Pulmonary epitheloid hemangioendothelioma PET CT findings and review of literature[J].Ann Saudi Med, 2014, 34 (5) :447-449.
|
|
[10]CHEVREAU C, le CESNE A, ITALIANO A, et al.Sorafenib in patients with progressive epithelioid hemangioendothelioma:Aphase 2 study by the French Sarcoma Group (GSF/GETO) [J].Cancer, 2013, 119 (14) :2639-2644.
|
|
[11]LI J, QIN S, XU J, et al.Randomized, double-blind, placebo-controlled phase III trial of apatinib in patients with chemotherapy-refractory advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction[J].J Clin Oncol, 2016, 34 (13) :1448-1454.
|
|
[12]ZHENG Z, WANG H, JIANG H, et al.Apatinib for the treatment of pulmonary epithelioid hemangioendothelioma:A case report and literature review[J].Medicine, 2017, 96 (45) :e8507.
|
DownLoad: